Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol for fatigue in multiple sclerosis patients
RBR-5y5sm9Phase 2Recruiting
- Sponsor
- Hospital de Clínicas da Universidade Federal do Paraná
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of salbutamol in multiple sclerosis (MS) (2 arms), sponsored by Hospital de Clínicas da Universidade Federal do Paraná. Started Nov 2018; status: recruiting.
02
Drugs
salbutamol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on RBR-5y5sm9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5y5sm9.